Matthew May is currently the Senior Patient Partnership Director and Group Lead for pRED Neuroscience and Rare Diseases at Roche. They have been a member of EUPATI Switzerland since 2016 and previously served as the EUPATI Coordinator from 2017 to 2020. Matthew also held various roles in organizations such as Project Kobokara and the Drug Information Association, where they contributed as a Medical Officer and Admin. Assistant, among other positions. Matthew's academic achievements include earning a Master’s degree in Chemistry with Industrial Experience from The University of Edinburgh.
This person is not in the org chart
This person is not in any teams
This person is not in any offices